Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients
Abstract This study aimed to ascertain, for the first time, whether serum magnesium (Mg) concentration is affected by the presence of hepatocellular carcinoma (HCC). We retrospectively enrolled consecutive cirrhotic patients with a diagnosis of HCC (n = 130) or without subsequent evidence of HCC dur...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e03b74014f5a49358ccf27a3938f28e7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e03b74014f5a49358ccf27a3938f28e7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e03b74014f5a49358ccf27a3938f28e72021-12-02T16:24:56ZLow serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients10.1038/s41598-021-94509-62045-2322https://doaj.org/article/e03b74014f5a49358ccf27a3938f28e72021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94509-6https://doaj.org/toc/2045-2322Abstract This study aimed to ascertain, for the first time, whether serum magnesium (Mg) concentration is affected by the presence of hepatocellular carcinoma (HCC). We retrospectively enrolled consecutive cirrhotic patients with a diagnosis of HCC (n = 130) or without subsequent evidence of HCC during surveillance (n = 161). Serum levels of Mg were significantly (P < 0.001) lower in patients with HCC than in those without (median [interquartile range]: 1.80 [1.62–1.90] mg/dl vs. 1.90 [1.72–2.08] mg/dl). On multivariate logistic regression, low serum Mg was associated with the presence of HCC (OR 0.047, 95% CI 0.015–0.164; P < 0.0001), independently from factors that can influence magnesaemia and HCC development. In a subset of 94 patients with HCC, a linear mixed effects model adjusted for confounders showed that serum Mg at diagnosis of HCC was lower than before diagnosis of the tumor (β = 0.117, 95% CI 0.039–0.194, P = 0.0035) and compared to after locoregional treatment of HCC (β = 0.079, 95% CI 0.010–0.149, P = 0.0259), with two thirds of patients experiencing these changes of serum Mg over time. We hypothesize that most HCCs, like other cancers, may be avid for Mg and behave like a Mg trap, disturbing the body’s Mg balance and resulting in lowering of serum Mg levels.Simona ParisseFlaminia FerriMarzia PersichettiMonica MischitelliAurelio AbbatecolaMichele Di MartinoQuirino LaiSara CarnevalePierleone LucatelliMario BezziMassimo RossiAdriano De SantisAlessandra SpagnoliStefano Ginanni CorradiniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Simona Parisse Flaminia Ferri Marzia Persichetti Monica Mischitelli Aurelio Abbatecola Michele Di Martino Quirino Lai Sara Carnevale Pierleone Lucatelli Mario Bezzi Massimo Rossi Adriano De Santis Alessandra Spagnoli Stefano Ginanni Corradini Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients |
description |
Abstract This study aimed to ascertain, for the first time, whether serum magnesium (Mg) concentration is affected by the presence of hepatocellular carcinoma (HCC). We retrospectively enrolled consecutive cirrhotic patients with a diagnosis of HCC (n = 130) or without subsequent evidence of HCC during surveillance (n = 161). Serum levels of Mg were significantly (P < 0.001) lower in patients with HCC than in those without (median [interquartile range]: 1.80 [1.62–1.90] mg/dl vs. 1.90 [1.72–2.08] mg/dl). On multivariate logistic regression, low serum Mg was associated with the presence of HCC (OR 0.047, 95% CI 0.015–0.164; P < 0.0001), independently from factors that can influence magnesaemia and HCC development. In a subset of 94 patients with HCC, a linear mixed effects model adjusted for confounders showed that serum Mg at diagnosis of HCC was lower than before diagnosis of the tumor (β = 0.117, 95% CI 0.039–0.194, P = 0.0035) and compared to after locoregional treatment of HCC (β = 0.079, 95% CI 0.010–0.149, P = 0.0259), with two thirds of patients experiencing these changes of serum Mg over time. We hypothesize that most HCCs, like other cancers, may be avid for Mg and behave like a Mg trap, disturbing the body’s Mg balance and resulting in lowering of serum Mg levels. |
format |
article |
author |
Simona Parisse Flaminia Ferri Marzia Persichetti Monica Mischitelli Aurelio Abbatecola Michele Di Martino Quirino Lai Sara Carnevale Pierleone Lucatelli Mario Bezzi Massimo Rossi Adriano De Santis Alessandra Spagnoli Stefano Ginanni Corradini |
author_facet |
Simona Parisse Flaminia Ferri Marzia Persichetti Monica Mischitelli Aurelio Abbatecola Michele Di Martino Quirino Lai Sara Carnevale Pierleone Lucatelli Mario Bezzi Massimo Rossi Adriano De Santis Alessandra Spagnoli Stefano Ginanni Corradini |
author_sort |
Simona Parisse |
title |
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients |
title_short |
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients |
title_full |
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients |
title_fullStr |
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients |
title_full_unstemmed |
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients |
title_sort |
low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/e03b74014f5a49358ccf27a3938f28e7 |
work_keys_str_mv |
AT simonaparisse lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT flaminiaferri lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT marziapersichetti lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT monicamischitelli lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT aurelioabbatecola lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT micheledimartino lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT quirinolai lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT saracarnevale lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT pierleonelucatelli lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT mariobezzi lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT massimorossi lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT adrianodesantis lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT alessandraspagnoli lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients AT stefanoginannicorradini lowserummagnesiumconcentrationisassociatedwiththepresenceofviablehepatocellularcarcinomatissueincirrhoticpatients |
_version_ |
1718384084956217344 |